Perhaps most significantly, we demonstrate that pharmacological intervention to inhibit EZH2 in an immune-competent preclinical mouse model of Luminal B breast cancer completely prevents distal metastasis (Fig. 2). The gene discussed is EZH2; the disease is breast carcinoma.